Clinical Trial Update: Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dupilumab for chronic hand eczema refractory to highly potent topical corticosteroids completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Eczema

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Chronic Hand Eczema | Phase 2 | Status: COMPLETED